Biolife Plasma Services, Lp

CLIA Laboratory Citation Details

2
Total Citations
4
Total Deficiencyies
4
Unique D-Tags
CMS Certification Number 03D2145340
Address 16480 N 59th Ave, Glendale, AZ, 85306
City Glendale
State AZ
Zip Code85306
Phone(602) 687-5999

Citation History (2 surveys)

Survey - April 8, 2025

Survey Type: Standard

Survey Event ID: E0G911

Deficiency Tags: D3031

Summary:

Summary Statement of Deficiencies D3031 RETENTION REQUIREMENTS CFR(s): 493.1105(a)(3) Analytic systems records. Retain quality control and patient test records (including instrument printouts, if applicable) and records documenting all analytic systems activities specified in 493.1252 through 493.1289 for at least 2 years. In addition, retain the following: This STANDARD is not met as evidenced by: Based on review of calibration verification records on April 8, 2025, lack of the manufacturer's package insert for calibration verification material and interview with the facility personnel, the laboratory failed to retain the manufacturer's assay sheets for at least 2 years for each lot of calibration verification material used by the laboratory during each semiannual calibration verification event in 2024 and one out of two calibration verification events in 2025. Findings include: 1. The laboratory performs total protein testing on 7 refractometers in the specialty of Chemistry, with a reported annual test volume of 108,224. 2. The laboratory's established policy (SOP- 243891, page 5) states, "Refer to the manufacturer's package insert to ensure that selected assay ranges are those specified for the brand of refractometer used. The manufacturer's package insert must be retained for future reference." 3. Review of the semiannual calibration verification records from 2024 and 2025 indicated the laboratory performed a calibration verification on each refractometer on the following dates: 1/10/24, 2/14/24, 7/11/24 and 1/17/25. 4. The laboratory failed to provide evidence of the manufacturer's assay sheets for each lot of calibration verification material used during each calibration verification event listed above. 5. The facility personnel interviewed on 4/08/25 at 11:10 AM confirmed the laboratory failed to retain the manufacturer's assay information sheets for at least 2 years for each lot of calibration verification material used by the laboratory during 2024 and in January 2025. Statement of Deficiencies (X1) Provider/Supplier/CLIA Identification Number (X3) Date Survey Completed Name of Provider or Supplier Street Address, City, State -- 1 of 1 --

πŸ”’ Unlock Deficiency Summary

Get full access to the detailed deficiency summary for this facility

One-time payment β€’ Lifetime access

Survey - November 7, 2023

Survey Type: Standard

Survey Event ID: 4BLL11

Deficiency Tags: D2015 D2009 D5403

Summary:

Summary Statement of Deficiencies D2009 TESTING OF PROFICIENCY TESTING SAMPLES CFR(s): 493.801(b)(1) The individual testing or examining the samples and the laboratory director must attest to the routine integration of the samples into the patient workload using the laboratory's routine methods. This STANDARD is not met as evidenced by: Based on review of proficiency testing (PT) records from 2021, 2022, and 2023 and interview with facility personnel, the laboratory director and testing personnel failed to sign the PT attestation statements. Findings include: 1. The laboratory performs testing in the speciality of Chemistry with an annual test volume of 92,338. 2. The PT attestation statements presented for review for the first, second and third events of 2021 and first, second and third events of 2022 lacked the signatures of the laboratory director and testing personnel. 3. The PT attestation statement presented for review for the first event of 2023 lacked the testing personnel's signature. 4. The facility personnel interviewed on 11/07/23 at 10:00 AM confirmed that the PT attestation statements indicated above were not signed by the laboratory director and testing personnel. D2015 TESTING OF PROFICIENCY TESTING SAMPLES CFR(s): 493.801(b)(5)(6) (5) The laboratory must document the handling, preparation, processing, examination, and each step in the testing and reporting of results for all proficiency testing samples. The laboratory must maintain a copy of all records, including a copy of the proficiency testing program report forms used by the laboratory to record proficiency testing results including the attestation statement provided by the PT program, signed by the analyst and the laboratory director, documenting that proficiency testing samples were tested in the same manner as patient specimens, for a minimum of two Statement of Deficiencies (X1) Provider/Supplier/CLIA Identification Number (X3) Date Survey Completed Name of Provider or Supplier Street Address, City, State -- 1 of 3 -- years from the date of the proficiency testing event. (6) PT is required for only the test system, assay, or examination used as the primary method for patient testing during the PT event. This STANDARD is not met as evidenced by: Based on lack of proficiency testing (PT) attestation statements for review from 2023 and interview with the facility personnel, the laboratory failed to provide evidence of the attestation statement provided by the PT program, signed by the analyst and the laboratory director, documenting that proficiency testing samples were tested in the same manner as patient specimens. Findings include: 1. The laboratory performs testing in the speciality of Chemistry with an annual test volume of 92,338. 2. The laboratory participates in three PT events annually for Total Protein. 3. During the survey on 11/07/23, the laboratory failed to provide evidence of the signed PT attestation statements for the second and third PT events of 2023. 4. The facility personnel interviewed on 11/07/23 at 10:05 AM confirmed the attestation statements indicated above were not available for review at the time of the survey. D5403 PROCEDURE MANUAL CFR(s): 493.1251(b) The procedure manual must include the following when applicable to the test procedure: (1) Requirements for patient preparation; specimen collection, labeling, storage, preservation, transportation, processing, and referral; and criteria for specimen acceptability and rejection as described in 493.1242. (2) Microscopic examination, including the detection of inadequately prepared slides. (3) Step-by-step performance of the procedure, including test calculations and interpretation of results. (4) Preparation of slides, solutions, calibrators, controls, reagents, stains, and other materials used in testing. (5) Calibration and calibration verification procedures. (6) The reportable range for test results for the test system as established or verified in 493.1253. (7) Control procedures. (8)

πŸ”’ Unlock Deficiency Summary

Get full access to the detailed deficiency summary for this facility

One-time payment β€’ Lifetime access